Discover and read the best of Twitter Threads about #bigstory
Most recents (5)
The latest #CounteringKleptocracy newsletter from @ThinkDemocracy is out! Read this thread to see some of the highlights from the March edition.
ned.org/countering-kle…
ned.org/countering-kle…
In the #BigStory, @ThinkDemocracy’s Ariane Gottlieb and @AidanMcGahey discuss how kleptocracy has fueled Tehran’s repression of the #WomanLifeFreedom protests.
Russia’s invasion of Ukraine brought with it numerous sanctions against Russian oligarchs—but Moscow’s elite are finding new and innovative ways to subvert these measures. economist.com/finance-and-ec…
This week, our #BigStory is a hunt for an Emeergency Contraceptive Pill in Chennai. Why did we do this? A few months ago, when we did a similar story, Health Minister @Subramanian_ma said it is available in govt hospitals. Really? We checked
But our reporting was not limited to doing ground checks. We got RTI responses from 45 from government general hospitals across the state. @KuthaliPu and @NidharshanaR write on what the RTIs said and the dissonance on ground. thenewsminute.com/article/tnm-in…
These two young reporters did get an ECP at one hospital. But it came with a heavy price called humiliation. Unmarried women asking for ECPs, you can imagine the stares and whispers. They chronicled it here. thenewsminute.com/article/dehuma…
#BigStory
The Brazilian government’s deal to import 20 million doses of Bharat Biotech’s Covaxin has sparked an investigation into corruption—raising questions about the involvement of President #Bolsonaro and about the vaccine itself.
The Brazilian government’s deal to import 20 million doses of Bharat Biotech’s Covaxin has sparked an investigation into corruption—raising questions about the involvement of President #Bolsonaro and about the vaccine itself.
In a deal signed in February, the Brazilian Health ministry agreed to pay $320 million for 20 million doses of Covaxin—at an eye-watering price of $15 per dose. The agreement was signed with a ‘middleman’ company called Precisa Medicamentos.
Bolsonaro’s mishandling of the pandemic is currently being investigated by a parliamentary commission. 2 big government contracts—one to buy Covaxin and the other to purchase raw materials for the drug Hydroxychloroquine—have raised a lot of red flags.
#BigStory
For the past few years, the govt has been tightening the screws on foreign-owned e-commerce giants—to favour Indian traders and merchants and local rivals. The latest salvo will come as a big blow to these platforms, and its biggest sellers and also you, dear customer.
For the past few years, the govt has been tightening the screws on foreign-owned e-commerce giants—to favour Indian traders and merchants and local rivals. The latest salvo will come as a big blow to these platforms, and its biggest sellers and also you, dear customer.
In Jan 2020, the Competition Commission of India, opened a probe into Amazon and Flipkart, citing four anti-competitive practices: exclusive launch of mobile phones , promoting preferred sellers, deep discounting, and prioritizing some seller listings over others.
Both Amazon and Flipkart are currently in court, fiercely fighting to block the probe. The government has moved to strike a potentially decisive blow to Amazon and Flipkart. It unveiled a draft of a new ecommerce policy that stipulates:
#BigStory | @ICMRDELHI to Launch 'BBV152 COVID' Vaccine for Public Use in India by August 15
weather.com/en-IN/india/co…
(Representational image: Mohammed Mohammed/Xinhua/IANS)
#covid19 #coronavirus
weather.com/en-IN/india/co…
(Representational image: Mohammed Mohammed/Xinhua/IANS)
#covid19 #coronavirus
The Indian Council of Medical Research (ICMR) plans to launch an indigenous vaccine for #COVID19 by Aug 15 after the completion of the clinical trials. It has selected 13 institutions across the country for clinical trials, and asked them to initiate subject enrollment by July 7.
.@ICMRDELHI Director General Balram Bhargava, in a letter to the heads of the selected institutions,informed them that it has partnered with Hyderabad-based Bharat Biotech International Limited to fast-track clinical trials of indigenous COVID-19 vaccine (BBV152 COVID vaccine).
